Aktuellt
SENASTE
Redeye endorses today’s news that Nanexa has signed an evaluation agreement with a global pharmaceutical company, that also includes an option to license Pharmashell (a new addition compared to previous agreements, we judge). While the evaluation likely will take some time, we are positive to the fact that new companies are interested in the platform, which should increase the odds for a full licensing agreement over time. The share price is up some 15% today, which we think is a fair reaction given the depressed sentiment surrounding the share lately.
LÄS MER
